Gianni, L. ., Mansutti, M. ., Anton, A. ., Calvo, L. ., Bisagni, G. ., Bermejo, B. ., … Tusquets, I. . (2018). Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-the Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical Trial. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2017.4612 (Original work published 2018)